In today's news:
From Reuters:
U.S. health regulators on Friday said they have received more than 40 reports of a type of blindness in men taking impotence drugs, mostly involving Pfizer Inc.'s Viagra.
The U.S. Food and Drug Administration said it has received about 38 reports of the rare condition among users of Viagra, four reports of blindness among users of Eli Lilly and Co.'s Cialis and one report of the condition in men talking Levitra, made by GlaxoSmithKline Plc.
Pfizer said outside of clinical trials, Viagra has been used by more than 23 million men worldwide over the past seven years. It said reports are extremely rare of visual loss due to the condition known as non-arteritic anterior ischemic optic neuropathy (NAION).
"FDA is aware of these reports but has not determined there is a cause and effect due to use of Viagra ... We're working with the company to make sure this information is available to doctors and patients," FDA spokeswoman Susan Cruzan told Reuters.
New York-based Pfizer acknowledged the rare cases of blindness and is weighing a label change. But it emphasized no proof exists that the blindness is linked to the drug, which was introduced in 1998 and had $1.68 billion in sales in 2004.
"We are in discussions with the FDA to update our language to reflect these rare ocular events that have occurred," Pfizer spokesman Daniel Watts said.
Terry Preston's in-depth views on the pressing issues of the day, from God, sex and national politics to the high price of a good beer at the ballgame. Any and all comments to these comments are encouraged.
Friday, May 27, 2005
Subscribe to:
Post Comments (Atom)
1 comment:
Which brings us to the classic "Good News, Bad News" conundrum of being blind, but not caring what your date looks like.
Post a Comment